The regular posting of new licensing opportunities, in-licensing needs and updated statistics are just some of the most useful services from Pharmalicensing, according to Giovanna Naldini at Abiogen Pharma.

Abiogen has been with Pharmalicensing for three years and during that time it has received many useful contacts and leads, including companies Giovanna Naldini feels it would not normally reach without the help of Pharmalicensing.

Abiogen is a research-focused pharmaceutical and manufacturing company located in Pisa, Italy. The company has launched four bisphosphonates based on its osteoarticular studies and is currently developing studies in central nervous system diseases and tumors. Pharmalicensing features Abiogen’s licensing prospects on its website, including an oncology licensing opportunity (disodium clodronate capsules) and CNS licensing need (dossier acquisition for paracetamol and codeine).

“There are so many companies out there and it is impossible to reach all of them, but by joining Pharmalicensing we have been able to make contacts that have been beneficial to us,” explains Ms Naldini.

Ms Naldini uses Pharmalicensing to look at their three posted licensing prospects and check the email alerts generated from these. She also checks the website about once or twice a month to see any new licensing opportunities and needs posted by other companies. She says, “Pharmalicensing has allowed us to advertise not only our company but our individual opportunities.”

Ms Naldini recalled an occasion that occurred a short period ago when Abiogen had a query regarding the number of licensing opportunities they were entitled to. To illustrate the advantages of featuring opportunities on the website, Pharmalicensing offered Abiogen a free posting of its opportunity. Ms Naldini and Abiogen found this “very impressive” and “a kind offer from Pharmalicensing.”

The relationship between Abiogen and Pharmalicensing is going very well and this is set to carry on in the future as Ms Naldini explained, “I am happy to continue with this co-operative relationship and the very quick responses we get from Pharmalicensing.” Ms Naldini used a similar partnering company, to post an opportunity on but did not receive as many responses as from Pharmalicensing, so feels sure that Abiogen has made a good choice with Pharmalicensing. She has not had the chance to recommend Pharmalicensing yet but if asked to recommend a partnering company she said she certainly would.